Biohaven (BHVN) Other financing activities (2021 - 2026)
Biohaven (BHVN) posted Other financing activities of -$1.8 million for Q4 2025, down 212.37% sequentially from $1.6 million in Q3 2025, and up 72.14% YoY from -$1.0 million in Q4 2024.
Biohaven (BHVN) Other financing activities (2021 - 2026) Analysis & Trends
Biohaven has reported Other financing activities for 5 years, with the latest figure at -$1.8 million in Q4 2025.
- Quarterly Other financing activities rose 72.14% year-over-year to -$1.8 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was -$563000.0 (down 140.01% YoY) and the FY2025 annual result came in at -$194000.0, down 108.59% from the prior year.
- Other financing activities declined to -$1.8 million in Q4 2025 per BHVN's latest filing, from $1.6 million in the prior quarter.
- Over five years, Other financing activities peaked at $86.8 million in Q2 2022 and troughed at -$252.4 million in Q4 2021.
- A 5-year average of -$21.0 million and a median of $794000.0 in 2023 frame the typical range for Other financing activities.
- The widest YoY moves for Other financing activities: up 456.48% in 2024, down 234.7% in 2024.
- Over 5 years, Other financing activities stood at -$252.4 million in 2021, then grew by 6.11% to -$237.0 million in 2022, then jumped by 101.98% to $4.7 million in 2023, then tumbled by 234.7% to -$6.3 million in 2024, then surged by 72.14% to -$1.8 million in 2025.
- According to Business Quant data, Other financing activities over the past three periods registered -$1.8 million, $1.6 million, and -$369000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Biohaven | 2.21 Bn | 1.94 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.80 Mn |
| Jun 30, 2026 | 3.80 Mn |
| Mar 31, 2026 | 132,000.00 |
| Mar 31, 2026 | 132,000.00 |
| Dec 31, 2025 | -1.76 Mn |
| Dec 31, 2025 | -1.76 Mn |
| Sep 30, 2025 | 1.57 Mn |
| Sep 30, 2025 | 1.57 Mn |
| Jun 30, 2025 | -369,000.00 |
| Jun 30, 2025 | -369,000.00 |
| Mar 31, 2025 | 369,000.00 |
| Mar 31, 2025 | 369,000.00 |
| Dec 31, 2024 | -6.32 Mn |
| Dec 31, 2024 | -6.32 Mn |
| Sep 30, 2024 | 4.01 Mn |
| Sep 30, 2024 | 4.01 Mn |
| Jun 30, 2024 | 3.35 Mn |
| Jun 30, 2024 | 3.35 Mn |
| Mar 31, 2024 | 1.22 Mn |
| Mar 31, 2024 | 1.22 Mn |